Evotec (EVO) Institutional Ownership → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free EVO Stock Alerts $5.27 +0.08 (+1.54%) (As of 05/9/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Evotec (NASDAQ:EVO)CurrentInstitutional OwnershipPercentage5.81%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$54.78MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$2.40M Get EVO Insider Trade Alerts Want to know when executives and insiders are buying or selling Evotec stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EVO Institutional Buying and Selling by Quarter Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Evotec Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/5/2024Mubadala Investment Co PJSC4,597,701$53.93M0.2%N/A1.297% 2/13/2024Optiver Holding B.V.80,810$945K0.0%+643.1%0.023% 2/8/2024Quadrant Capital Group LLC2,130$25K0.0%N/A0.001% 1/31/2024Federated Hermes Inc.576,933$6.74M0.0%-0.3%0.163% 1/30/2024 Zurcher Kantonalbank Zurich Cantonalbank174,266$2.04M0.0%-13.9%0.049% 11/13/2023Optiver Holding B.V.10,874$107K0.0%-68.0%0.003% 11/13/2023Federated Hermes Inc.578,533$5.71M0.0%-22.9%0.163% 10/25/2023 Zurcher Kantonalbank Zurich Cantonalbank202,368$2.00M0.0%-6.2%0.057% (Data available from 1/1/2016 forward) EVO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EVO shares? During the previous two years, the following institutional investors and hedge funds held shares of Evotec shares: Mubadala Investment Co PJSC ($53.93M), Federated Hermes Inc. ($6.74M), Zurcher Kantonalbank Zurich Cantonalbank ($2.04M), and Optiver Holding B.V. ($945K), Quadrant Capital Group LLC ($25K).Learn more on EVO's institutional investors. What percentage of Evotec stock is owned by institutional investors? 5.81% of Evotec stock is owned by institutional investors. Learn more on EVO's institutional investor holdings. Which institutional investors have been buying Evotec stock? The following institutional investors have purchased Evotec stock in the last 24 months: Mubadala Investment Co PJSC ($4.60M), Optiver Holding B.V. ($69.94K), and Quadrant Capital Group LLC ($2.13K). How much institutional buying is happening at Evotec? Institutional investors have bought a total of 4,669,767 shares in the last 24 months. This purchase volume represents approximately $54.78M in transactions. Which Evotec major shareholders have been selling company stock? The following institutional investors have sold Evotec stock in the last 24 months: Federated Hermes Inc. ($173.07K), Zurcher Kantonalbank Zurich Cantonalbank ($41.40K), and Optiver Holding B.V. ($23.08K). How much institutional selling is happening at Evotec? Institutional investors have sold a total of 237,551 shares in the last 24 months. This volume of shares sold represents approximately $2.40M in transactions. Related Companies: Structure Therapeutics Major Shareholders Agios Pharmaceuticals Major Shareholders Amneal Pharmaceuticals Major Shareholders Galapagos Major Shareholders Syndax Pharmaceuticals Major Shareholders Catalyst Pharmaceuticals Major Shareholders Schrödinger Major Shareholders Harmony Biosciences Major Shareholders Avidity Biosciences Major Shareholders NewAmsterdam Pharma Major Shareholders This page (NASDAQ:EVO) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evotec SE Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.